Corcept Therapeutics Inc (CORT)
52.17
+1.27
(+2.50%)
USD |
NASDAQ |
Dec 24, 16:00
Corcept Therapeutics Cash from Investing (Quarterly): -44.04M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ADMA Biologics Inc | -1.098M |
| Catalyst Pharmaceuticals Inc | -0.259M |
| Madrigal Pharmaceuticals Inc | -202.39M |
| Alnylam Pharmaceuticals Inc | -30.25M |
| Ionis Pharmaceuticals Inc | -340.80M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 73.83M |
| Cash from Financing (Quarterly) | -21.09M |
| Free Cash Flow | 142.60M |
| Free Cash Flow Per Share (Quarterly) | 0.6348 |
| Free Cash Flow to Equity (Quarterly) | 72.19M |
| Free Cash Flow to Firm (Quarterly) | 72.19M |
| Free Cash Flow Yield | 2.45% |